Udvidet returret til 31. januar 2017

Du er her:
Bog, hardback Immunotherapy of Melanoma af Anand Rotte

Immunotherapy of Melanoma

- 2017

(Bog, hardback)

Introducing metastatic melanomas, this book details diagnosis, clinical symptoms, types and AJCC staging, followed by a discussion of treatment problems and how immunotherapy provided the solution. The immune system, approved drugs and their molecular action are discussed, with the mo... Læs mere

Introducing metastatic melanomas, this book details diagnosis, clinical symptoms, types and AJCC staging, followed by a discussion of treatment proble... Læs mere

Produktdetaljer:

Sprog:
Engelsk
ISBN-13:
9783319480657
Sideantal:
500
Udgivet:
06-01-2017
Vis mere

Sæt bog på liste

  • Bogliste

 
kr. 1.899,95
Forventes udgivet
06-01-2017
Leveringstid
Kan forudbestilles
Leveres senest
06-01-2017
-34%

kr. 1.240,66
Din studiepris
Fragt
Gratis



Forlagets beskrivelse
Introducing metastatic melanomas, this book details diagnosis, clinical symptoms, types and AJCC staging, followed by a discussion of treatment problems and how immunotherapy provided the solution. The immune system, approved drugs and their molecular action are discussed, with the most promising candidates from ongoing clinical trials. 7 black & white illustrations, 52 colour illustrations, biography
Bibliotekernes beskrivelse
Metastatic melanoma are introduced to the readers, giving details of the diagnosis, clinical symptoms, types and AJCC staging, followed by a discussion of problems in the treatment of melanoma and how immunotherapy provided the solution. Next an account of the immune system is given, describing its role in cancer prevention and discussing how immune check points are circumvented in cancer. Approved drugs are discussed together with their molecular mechanisms of action, response rates, survival benefits, pharmacokinetics and adverse effects. Finally this book discusses the most promising candidates from ongoing clinical trials and highlights challenges faced by immunotherapeutic drugs as well as strategies to overcome them. Metastatic melanoma is a deadly type of skin cancer, known for its resistance to conventional treatments. For decades, patients were managed with a handful of drugs that had minimal survival benefits. The scenario changed with the approval of inhibitors of BrafV600E and MEK, and monoclonal antibodies against CTLA4. While the kinase inhibitors were promising in the initial studies, they suffered with the development of lethal resistance.Anti-CTLA4 monoclonal antibodies (Ipilimumab) on the other hand provided long term survival benefits in responding patients and there were no reports of resistance. However, response rate for Ipilimumab was very low. Recently, monoclonal antibodies against PD-1 receptors (Nivolumab, Pembrolizumab) were approved by FDA for the treatment of melanoma, extending the hope for melanoma patients. This book provides detailed information on immunotherapeutic drugs for melanoma management - it describes melanoma, discusses issues in melanoma treatment and highlights the successes of immunotherapy in the treatment.

Kundernes boganmeldelser af Immunotherapy of Melanoma

Anmeld bogen og vær med i konkurrencen om gavekort – læs mere her.

Der er ingen anmeldelser af Immunotherapy of Melanoma

for at skrive en anmeldelse.

Bogens kategori: